Drugs / DCL-101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02910440 | Jan → Nov 2017 | — | Dark Canyon Laboratories, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCL-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02910440 ↗ |
| Route | Oral | “DCL-101, a novel Pill Prep” PMID 33512795 ↗ Dec 2020 |